17136-54-8Relevant articles and documents
Method for synthesizing L -selenium - methylselenocysteine
-
Paragraph 0053; 0055, (2021/11/27)
The invention provides a method for synthesizing L -selenium - methylselenocysteine, and relates to the reaction of a compound of formula II or a salt thereof with dimethyl diselenoate, and the method comprises MBH. 4 The method comprises the following steps: directly synthesizing L - selenium - methylselenocysteine through a one-pot reaction under the action of alkali or synthesizing L - selenium - methylselenocysteine, and hydrolyzing to obtain L - selenium - methylselenocysteine. The synthesis method has the advantages of simple reaction. The method has the advantages of convenient operation, high product yield, good quality, low cost and suitability for industrialization.
N-acetyl-β-chloro-L-alanine methyl ester preparation method
-
Paragraph 0046, (2016/10/17)
The invention provides a method for preparing N-acetyl-beta-chlorine-L-alanine methyl ester. The method includes the steps that (a) serine serves as a starting material and is esterified through methanol or ethyl alcohol, (b) the esterified matter is chlorinated through sulfoxide chloride, (c) the chlorinated matter undergoes acylation, (d) the acylated matter is recrystallized, and accordingly the N-acetyl-beta-chlorine-L-alanine methyl ester is obtained. The method is high in reaction yield, by-products are few, reaction mother liquor is recycled and reused, distilled liquid obtained after acylation is acetic acid and acetic anhydride, and the liquid is recycled and reused after being purified. Accordingly, cost is low, tail gas generated in reactions is absorbed through strong-base solutions to form salt and then is separated and used, and accordingly environment protection is achieved.
Dual inhibition of human leukocyte elastase and lipid peroxidation: In vitro and in vivo activities of azabicyclo[2.2.2]octane and perhydroindole derivatives
Portevin, Bernard,Lonchampt, Michel,Canet, Emmanuel,De Nanteuil, Guillaume
, p. 1906 - 1918 (2007/10/03)
A series of potent and selective human leukocyte elastase (HLE) inhibitors of the Val-Pro-Val type has been developed. Initially, the central proline residue was replaced by nonnatural amino acids Phi ((2S,3aS,7aS)- perhydroindole-2-carboxylic acid) and A